drugset / Trial / NCT05117034

Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.

NCT05117034

Active not recruiting 115 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We propose a double-blind randomized controlled trial to evaluate the effect of intravenously administered morphine at surgery conclusion on acute postoperative pain in patients recovering from craniotomy surgery. Participating adults having craniotomy surgery will be randomized in a 1:1 ratio to intraoperative intravenous administration of 0.08 mg/kg morphine at dura closure, or a matching placebo.

Timeline

Start
2022-02-16
Primary completion
2025-05-01
Completion
2025-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 0.08 mg/kg Intravenous

Indications